<DOC>
	<DOCNO>NCT00345072</DOCNO>
	<brief_summary>The purpose study develop test web-based system intend help woman go menopause make informed choice regard menopause treatment . The system give woman personalize feedback risks benefit treatment .</brief_summary>
	<brief_title>A Menopause Interactive Decision Aid System</brief_title>
	<detailed_description>Most woman satisfy counsel receive menopause . To improve menopause counsel help menopausal woman actively participate decision making process , develop novel prototype web-based decision aid . Our immediate goal develop prototype technology comprehensive Menopause Interactive Decision Aid System ( MIDAS ) provide personalized feedback menopausal symptom , risk common condition , effect different treatment option short- long-term consequence menopause . Our main study hypothesis MIDAS : 1 ) lead well decision improve quality menopausal counseling ; 2 ) improve compliance choose menopausal plan ; 3 ) reduce medical error associate use menopausal therapy . We propose 2-phase study conduct 3 year . Phase I transform prototype application comprehensive MIDAS , complete content risk assessment instrument , explore optimal design . This accomplished conduct focus group usability test . Phase II formally evaluate impact MIDAS randomize , control , multi-center clinical trial involve diverse patient population clinician setting . We measure impact MIDAS decision-making process well effect provider outcome measure relate menopause , include compliance , quality life , medical error relate menopausal therapy . Analyses evaluate extent impact MIDAS outcomes varies accord patient , practice , physician characteristic .</detailed_description>
	<criteria>Englishspeaking Between 45 65 year age Patient participate clinic Experience menopausal symptom 6 month past last menstrual period Have upcoming appointment menopausal counsel annual physical exam ( applicable clinical trial participant ) Inability give inform consent Dementia Age 65 year Preexisting terminal illness limit life expectancy le 2 year History breast cancer cardiovascular disease</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Decision aid</keyword>
	<keyword>Internet</keyword>
	<keyword>Hormone Replacement Therapy</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>Osteoporosis</keyword>
</DOC>